Individualizing Treatment to Advance Integration of New Evidence and Quality Care in von Willebrand Disease
hosted byPrime Education, LLCIndividualizing Treatment to Advance Integration of New Evidence and Quality Care in von Willebrand Disease is organized by Prime Education, LLC.
Release Date: March 31, 2023
Expiration Date: March 30, 2024
Description:
The heterogeneity of von Willebrand disease (VWD) makes individualized care planning essential to optimize quality of life and patient outcomes. Evolving treatment guidelines and the complex nature of VWD treatment and management also preclude integration of the latest evidence and treatment advances into clinical practice.
Join us for this webcast from the satellite symposium at the 2023 Hemostasis and Thrombosis Research Society Scientific Symposium (HTRS) in Orlando, FL. Leading experts review real-world clinical decision-making revealing gaps in knowledge, challenges, and barriers in integrating the latest advances into treatment and management of VWD. Through challenging, case-based discussion, experts take a deeper dive into current evidence, guideline recommendations, and patient-specific characteristics, as well as individual provider and patient goals to guide development of individualized treatment plans.
Don't miss the opportunity to:
• Examine NEW real-world data from providers on gaps in VWD management and care
• Hear expert strategies for incorporating the latest clinical evidence and patient-level factors into individualized treatment strategies
• Hone your skills in prophylactic strategies for patients with VWD experiencing severe and frequent bleeds
Agenda:
• Challenges in the Treatment and Management of von Willebrand Disease (VWD)
• Examining the Latest Clinical Data on On-Demand Treatment, Perioperative Management, and Routine Prophylaxis Approaches for VWD
• Applying Current Guidelines, Evidence, and Shared-Decision-Making to Individualize Treatment Based on VWD Type, Risk of Thrombosis, Clinical Characteristics, and Patient and Provider Goals
• Case Discussions: Prophylactic Strategies for Patients With VWD Experiencing Severe and Frequent Bleeds Despite On-Demand Treatment
Learning Objectives:
• Assess barriers and challenges contributing to gaps in evidence-based care for patients with von Willebrand disease (VWD)
• Differentiate VWD therapeutics based on indication, VWF/FVIII ratios, high molecular weight multimer content, and the latest clinical evidence for their safety and efficacy
• Apply current evidence, guideline recommendations, and patient-specific characteristics including VWD type, risk of thrombosis, clinical considerations (including prophylaxis, surgical intervention, and cardiovascular comorbidities), and individual provider and patient goals to guide development of individualized treatment plans
• Employ effective interprofessional strategies for patient engagement and shared treatment decision-making to optimize evidence-based, individualized long-term management of patients with VWD
